首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
【24h】

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.

机译:人类黑素瘤细胞中TNF相关凋亡诱导配体(TRAIL)的死亡和诱饵受体的差异化定位和调控。

获取原文
获取原文并翻译 | 示例
           

摘要

Induction of apoptosis in cells by TNF-related apoptosis-inducing ligand (TRAIL), a member of the TNF family, is believed to be regulated by expression of two death-inducing and two inhibitory (decoy) receptors on the cell surface. In previous studies we found no correlation between expression of decoy receptors and susceptibility of human melanoma cells to TRAIL-induced apoptosis. In view of this, we studied the localization of the receptors in melanoma cells by confocal microscopy to better understand their function. We show that the death receptors TRAIL-R1 and R2 are located in the trans-Golgi network, whereas the inhibitory receptors TRAIL-R3 and -R4 are located in the nucleus. After exposure to TRAIL, TRAIL-R1 and -R2 are internalized into endosomes, whereas TRAIL-R3 and -R4 undergo relocation from the nucleus to the cytoplasm and cell membranes. This movement of decoy receptors was dependent on signals from TRAIL-R1 and -R2, as shown by blocking experiments with Abs to TRAIL-R1 and -R2. The location of TRAIL-R1, -R3, and -R4 in melanoma cells transfected with cDNA for these receptors was similar to that in nontransfected cells. Transfection of TRAIL-R3 and -R4 increased resistance of the melanoma lines to TRAIL-induced apoptosis even in melanoma lines that naturally expressed these receptors. These results indicate that abnormalities in "decoy" receptor location or function may contribute to sensitivity of melanoma to TRAIL-induced apoptosis and suggest that further studies are needed on the functional significance of their nuclear location and TRAIL-induced movement within cells.
机译:TNF相关的凋亡诱导配体(TRAIL)(TNF家族的一个成员)对细胞凋亡的诱导被认为是由细胞表面上两个死亡诱导和两个抑制(诱饵)受体的表达所调节的。在先前的研究中,我们发现诱饵受体的表达与人类黑素瘤细胞对TRAIL诱导的细胞凋亡的敏感性之间没有关联。有鉴于此,我们通过共聚焦显微镜研究了黑素瘤细胞中受体的定位,以更好地了解其功能。我们表明,死亡受体TRAIL-R1和R2位于反式高尔基网络中,而抑制受体TRAIL-R3和-R4位于核中。暴露于TRAIL后,TRAIL-R1和-R2被内化为内体,而TRAIL-R3和-R4则从细胞核转移到细胞质和细胞膜。诱饵受体的这种移动取决于TRAIL-R1和-R2的信号,如对TRAIL-R1和-R2的Abs阻断实验所示。 TRAIL-R1,-R3和-R4在被这些受体的cDNA转染的黑素瘤细胞中的位置与未转染的细胞相似。 TRAIL-R3和-R4的转染增加了黑色素瘤细胞系对TRAIL诱导的细胞凋亡的抵抗力,即使在天然表达这些受体的黑色素瘤细胞系中也是如此。这些结果表明“诱饵”受体位置或功能的异常可能有助于黑色素瘤对TRAIL诱导的细胞凋亡的敏感性,并表明需要进一步研究其核位置和TRAIL诱导的细胞内运动的功能意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号